Two years after the UK Lighthouse Lab Network processed its first test, the end of March 2022 also coincides with the government’s plan to scale back on Covid-19 restrictions and testing.
Although this means the Alderley Park Lighthouse Lab (APLL) will be demobilised from April, the impact the lab made during the pandemic will leave a legacy that will be recognised for years to come.
The APLL team is delighted to have won a prestigious Bionow Award – an accolade given to honour those most deserving for their ingenuity and dedication, which serves as a fitting memento to the lab’s pandemic response.
The Alderley Park team was recognised in the Response to the Covid-19 Pandemic Award Sponsored by SRG, seeing off tough competition from across the UK, in a ceremony which showcases the very best the UK has to offer across its world-leading life sciences sector.
The APLL received the award for its integral role in the UK’s Covid-19 pandemic response, performing over 23 million Covid-19 PCR tests and training over 1,000 scientists over a two year period throughout the pandemic.
For a full list of winners of the 2021 Bionow Awards click here.
PACE (Pathways to Antimicrobial Clinical Efficacy) and the UK Health Security Agency (UKHSA) have released five new contemporary antimicrobial resistance (AMR) strain panels, giving innovators worldwide a resource to test novel therapeutics and diagnostics against today’s resistance patterns.
New appointments support MDC’s mission to turn drug discovery into commercial breakthroughs.
